IRadimed Corporation (IRMD)

IRadimed Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	65.56	53.3	41.81	31.72	38.52
Revenue Growth (YoY)	23.00%	27.48%	31.83%	-17.65%	26.54%
Cost of Revenue	15.4	12.02	9.76	8.14	8.82
Gross Profit	50.16	41.28	32.05	23.57	29.7
Selling, General & Admin	27.26	23.38	20.33	22.43	19.62
Research & Development	2.86	2.28	1.91	1.9	1.43
Operating Expenses	30.12	25.65	22.23	24.33	21.05
Operating Income	20.04	15.63	9.82	-0.76	8.65
Other Expense / Income	-1.7	-0.55	-0.02	-0.14	-0.4
Pretax Income	21.74	16.18	9.84	-0.62	9.04
Income Tax	4.55	3.35	0.51	-1.99	-0.59
Net Income	17.19	12.83	9.33	1.37	9.63
Net Income Growth	34.02%	37.56%	581.19%	-85.79%	52.79%
Shares Outstanding (Basic)	13	13	12	12	11
Shares Outstanding (Diluted)	13	13	13	13	12
Shares Change	0.69%	0.36%	0.61%	1.94%	1.37%
EPS (Basic)	1.36	1.02	0.76	0.12	0.85
EPS (Diluted)	1.35	1.02	0.74	0.11	0.78
EPS Growth	32.35%	37.84%	572.73%	-85.90%	50.00%
Free Cash Flow	5.46	8.17	10.52	5.18	9.75
Free Cash Flow Per Share	0.43	0.65	0.85	0.42	0.86
Dividend Per Share	1.680	1.000	-	-	-
Dividend Growth	68.00%	-	-	-	-
Gross Margin	76.50%	77.45%	76.65%	74.33%	77.11%
Operating Margin	30.56%	29.32%	23.48%	-2.38%	22.45%
Profit Margin	26.22%	24.07%	22.30%	4.32%	25.00%
Free Cash Flow Margin	8.32%	15.32%	25.15%	16.33%	25.31%
Effective Tax Rate	20.91%	20.72%	5.19%	-	-6.50%
EBITDA	22.5	16.85	11.24	0.72	10.29
EBITDA Margin	34.32%	31.61%	26.89%	2.28%	26.70%
Depreciation & Amortization	0.77	0.67	1.41	1.34	1.24
EBIT	21.74	16.18	9.84	-0.62	9.04
EBIT Margin	33.16%	30.36%	23.52%	-1.94%	23.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).